Eisai
4523.T
#2485
Rank
HK$59.24 B
Marketcap
HK$209.90
Share price
2.00%
Change (1 day)
-3.54%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): HK$6.78

According to Eisai's latest financial reports the company's current EPS (TTM) is HK$6.79. an increase over its 2024 EPS that were of HK$7.66.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025HK$8.5711.85%
2024HK$7.66-32.63%
2023HK$11.375.52%
2022HK$10.77-74.01%
2021HK$41.45-66.58%
2020HK$124.0198.24%
2019HK$62.5517.01%
2018HK$53.4637.78%
2017HK$38.80-27.62%
2016HK$53.6135.33%
2015HK$39.61-2.82%
2014HK$40.77-27.66%
2013HK$56.36-27.49%
2012HK$77.72-12.67%
2011HK$89.0088.08%
2010HK$47.32-11.06%
2009HK$53.21-390.15%
2008-HK$18.34-127.78%
2007HK$66.0211.78%
2006HK$59.074.38%
2005HK$56.597.4%
2004HK$52.6943.03%
2003HK$36.8425.09%
2002HK$29.4552.67%
2001HK$19.2969.76%
2000HK$11.36